Approaching IND: What To Consider In Early Development

When preparing for IND submission, drug developers must carefully consider multiple components of their program: analytical challenges, manufacturing and engineering controls, delivery systems, and more. They must also take into account the facilities in which the development and manufacturing of their programs take place. Partnering with an experienced CDMO can help relieve some of the pressure from emerging biotechs as they manage these moving pieces.

In this webinar, Cambrex experts discuss tips for optimizing your early development program and the benefits of housing all related activities under one roof.

Key Takeaways:

• How to understand and prevent pitfalls that could impact your early-stage program
• Key components necessary for proper CMC data within an IND submission
• How to find the right CDMO to prepare your molecule for IND and beyond